JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 5 No. 7, July 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL REVIEW
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Practice Commentary

Bruce G. Pollock, MD, PhD

Arch Fam Med. 1996;5(7):412.


References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.


1. Pollock BG. Recent developments in drug metabolism of relevance to psychiatrists. Harvard Rev Psychiatry. 1994;2:204-213. PUBMED
2. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 1996;153:311-320. FREE FULL TEXT
3. Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol. 1995;15:387-398. PUBMED
4. Swims MP. Potential terfenadine-fluoxetine interaction. Ann Pharmacother 1993;27:1404-1405. PUBMED
5. Rosenblatt JE, Rosenblatt NC. Sertraline-terfenadine interaction? Curr Affect Illness. 1996;15:14.
6. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA. 1993;269:1513-1518. FREE FULL TEXT